{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T13:01:23Z","timestamp":1775912483629,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T00:00:00Z","timestamp":1707091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.euf.2023.12.001","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T12:33:24Z","timestamp":1703853204000},"page":"581-593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Will Aquablation Be the New Benchmark for Robotic Minimally Invasive Surgical Treatment for Benign Prostatic Hyperplasia?"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2031-347X","authenticated-orcid":false,"given":"Carlotta","family":"Nedbal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Castellani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virgilio","family":"De Stefano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Giulioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Pirola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy Yuen-Chun","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean","family":"Elterman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhaskar Kumar","family":"Somani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vineet","family":"Gauhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2023.12.001_b0005","unstructured":"Cornu J, Gacci M, Hashim H, et al. EAU guidelines on non-neurogenic male lower urinary tract symptoms (LUTS) incl. benign prostatic obstruction (BPO). Arnhem, The Netherlands: European Association of Urology; 2023. p. 42\u20133. https:\/\/d56bochluxqnz.cloudfront.net\/documents\/full-guideline\/EAU-Guidelines-on-Non-Neurogenic-Male-LUTS-2023.pdf."},{"key":"10.1016\/j.euf.2023.12.001_b0010","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/JU.0000000000002184","article-title":"Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline part ii\u2014surgical evaluation and treatment","volume":"206","author":"Lerner","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2023.12.001_b0015","doi-asserted-by":"crossref","DOI":"10.4414\/SMW.2022.w30136","article-title":"In-hospital cost analysis of Aquablation compared with transurethral resection of the prostate in the treatment of benign prostatic enlargement","volume":"152","author":"M\u00fcllhaupt","year":"2022","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.euf.2023.12.001_b0020","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/bju.13358","article-title":"Aquablation \u2013 image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience","volume":"117","author":"Gilling","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2023.12.001_b0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/end.2014.0304","article-title":"Image-guided robot-assisted prostate ablation using water jet-hydrodissection: initial study of a novel technology for benign prostatic hyperplasia","volume":"29","author":"Faber","year":"2015","journal-title":"J Endourol"},{"key":"10.1016\/j.euf.2023.12.001_b0030","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.juro.2017.12.065","article-title":"WATER: a double-blind, randomized, controlled trial of Aquablation\u00ae vs transurethral resection of the prostate in benign prostatic hyperplasia","volume":"199","author":"Gilling","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2023.12.001_b0035","first-page":"8937","article-title":"How I do it: balloon tamponade of prostatic fossa following Aquablation","volume":"24","author":"Aljuri","year":"2017","journal-title":"Can J Urol"},{"key":"10.1016\/j.euf.2023.12.001_b0040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/bju.14360","article-title":"WATER II (80\u2013150 mL) procedural outcomes","volume":"123","author":"Desai","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2023.12.001_b0045","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/bju.14990","article-title":"Transfusion rates after 800 Aquablation procedures using various haemostasis methods","volume":"125","author":"Elterman","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2023.12.001_b0050","first-page":"10610","article-title":"Focal bladder neck cautery associated with low rate of post-Aquablation bleeding","volume":"28","author":"Elterman","year":"2021","journal-title":"Can J Urol"},{"key":"10.1016\/j.euf.2023.12.001_b0055","first-page":"222","article-title":"The combination of waterjet ablation (Aquabeam\u00ae) and holmium laser power for treatment of symptomatic benign prostatic hyperplasia: early functional results","volume":"74","author":"D\u2019Agostino","year":"2021","journal-title":"Cent Eur J Urol"},{"key":"10.1016\/j.euf.2023.12.001_b0060","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/bju.14426","article-title":"Symptom relief and anejaculation after aquablation or transurethral resection of the prostate: subgroup analysis from a blinded randomized trial","volume":"123","author":"Plante","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2023.12.001_b0065","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.urology.2018.12.002","article-title":"Randomized controlled trial of Aquablation versus transurethral resection of the prostate in benign prostatic hyperplasia: one-year outcomes","volume":"125","author":"Gilling","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.euf.2023.12.001_b0070","first-page":"9317","article-title":"Aquablation versus transurethral resection of the prostate: 1 year United States \u2013 cohort outcomes","volume":"25","author":"Kasivisvanathan","year":"2018","journal-title":"Can J Urol"},{"key":"10.1016\/j.euf.2023.12.001_b0075","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1007\/s12325-019-00952-3","article-title":"Two-year outcomes after Aquablation compared to TURP: efficacy and ejaculatory improvements sustained","volume":"36","author":"Gilling","year":"2019","journal-title":"Adv Ther"},{"key":"10.1016\/j.euf.2023.12.001_b0080","first-page":"10072","article-title":"Three-year outcomes after Aquablation therapy compared to TURP: results from a blinded randomized trial","volume":"27","author":"Gilling","year":"2020","journal-title":"Can J Urol"},{"key":"10.1016\/j.euf.2023.12.001_b0085","first-page":"10960","article-title":"Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH","volume":"29","author":"Gilling","year":"2022","journal-title":"Can J Urol"},{"key":"10.1016\/j.euf.2023.12.001_b0090","first-page":"11408","article-title":"Surgical treatment for BPH refractory to medication: robotic water jet ablation vs. TURP functional outcomes from two FDA clinical trials","volume":"30","author":"Te","year":"2023","journal-title":"Can J Urol"},{"key":"10.1016\/j.euf.2023.12.001_b0095","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.eururo.2014.06.017","article-title":"A Systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update","volume":"67","author":"Cornu","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2023.12.001_b0100","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.juro.2016.11.001","article-title":"Prospective assessment of learning curve of holmium laser enucleation of the prostate for treatment of benign prostatic hyperplasia using a multidimensional approach","volume":"197","author":"Elshal","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2023.12.001_b0105","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/bju.13124","article-title":"Multicentre prospective evaluation of the learning curve of holmium laser enucleation of the prostate (HoLEP)","volume":"117","author":"Robert","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2023.12.001_b0110","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/bju.14208","article-title":"Multicentre international experience of 532-nm laser photoselective vaporization with GreenLight XPS in men with very large prostates","volume":"122","author":"Valdivieso","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2023.12.001_b0115","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s00345-018-2509-y","article-title":"Aquablation of the prostate: single-center results of a non-selected, consecutive patient cohort","volume":"37","author":"Bach","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2023.12.001_b0120","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/bju.14703","article-title":"Aquablation for benign prostatic hyperplasia in large prostates (80\u2013150 mL): 6-month results from the WATER II trial","volume":"124","author":"Desai","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2023.12.001_b0125","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.eururo.2019.06.024","article-title":"Waterjet ablation therapy for treating benign prostatic obstruction in patients with small- to medium-size glands: 12-month results of the first French Aquablation clinical registry","volume":"76","author":"Misrai","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2023.12.001_b0130","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/bco2.121","article-title":"Aquablation therapy in large prostates (80\u2013150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3-year trial results","volume":"3","author":"Zorn","year":"2022","journal-title":"BJUI Compass"},{"key":"10.1016\/j.euf.2023.12.001_b0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.euros.2021.01.004","article-title":"WATER versus WATER II 2-year update: comparing Aquablation therapy for benign prostatic hyperplasia in 30\u201380-cm3 and 80\u2013150-cm3 prostates","volume":"25","author":"Nguyen","year":"2021","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euf.2023.12.001_b0140","first-page":"242","article-title":"The influence of the medical treatment of LUTS on benign prostatic hyperplasia surgery: do we operate too late?","volume":"69","author":"Presicce","year":"2017","journal-title":"Minerva Urol Nefrol"},{"key":"10.1016\/j.euf.2023.12.001_b0145","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s11934-996-0006-0","article-title":"The economics of benign prostatic hyperplasia and lower urinary tract symptoms in the United States","volume":"7","author":"Taub","year":"2006","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.euf.2023.12.001_b0150","doi-asserted-by":"crossref","first-page":"E113","DOI":"10.5489\/cuaj.5501","article-title":"Aquablation among novice users in Canada: a WATER II subpopulation analysis","volume":"13","author":"Zorn","year":"2018","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.euf.2023.12.001_b0155","first-page":"1","article-title":"Minimally invasive treatments for lower urinary tract symptoms due to benign prostatic hyperplasia","volume":"182","author":"Topfer","year":"2020","journal-title":"CADTH Issues Emerging Health Technol"},{"key":"10.1016\/j.euf.2023.12.001_b0160","unstructured":"National Institute for Health and Care Excellence. Medtech innovation briefing. NICE Guidelines. Aquablation robotic therapy for lower urinary tract symptoms caused by benign prostatic hyperplasia. National Institute for Health and Care Excellence website. September 13, 2023. https:\/\/www.nice.org.uk\/advice\/mib315."},{"key":"10.1016\/j.euf.2023.12.001_b0165","article-title":"Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis","volume":"2021","author":"Franco","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.euf.2023.12.001_b0170","first-page":"2214","article-title":"Defining minimal invasive surgical therapy for benign prostatic obstruction surgery: perspectives from a global knowledge, attitudes, and practices survey","author":"Cheng","year":"2022","journal-title":"Asian J Urol"},{"key":"10.1016\/j.euf.2023.12.001_b0175","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1590\/s1677-5538.ibju.2023.0016","article-title":"Novel minimally invasive treatments for lower urinary tract symptoms: a systematic review and network meta-analysis","volume":"49","author":"van Kollenburg","year":"2023","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.euf.2023.12.001_b0180","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.euf.2022.04.013","article-title":"Expectations facing reality: complication management after Aquablation treatment for lower urinary tract symptoms","volume":"8","author":"Probst","year":"2022","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euf.2023.12.001_b0185","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/JU.0000000000003483","article-title":"Aquablation therapy in large prostates (80\u2013150 mL) for lower urinary tract symptoms due to benign prostatic hyperplasia: final WATER II 5-year clinical trial results","volume":"210","author":"Bhojani","year":"2023","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2023.12.001_b0190","doi-asserted-by":"crossref","first-page":"351","DOI":"10.5152\/tud.2021.21126","article-title":"Evolution of AquablationVR\u2014from innovation to establishment","volume":"47","author":"Stein","year":"2021","journal-title":"Turk J Urol"},{"key":"10.1016\/j.euf.2023.12.001_b0195","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1089\/cren.2019.0123","article-title":"Aquablation for the treatment of benign prostatic hyperplasia in a large volume prostate with an intravesical median lobe","volume":"6","author":"Ghiraldi","year":"2020","journal-title":"J Endourol Case Rep"},{"key":"10.1016\/j.euf.2023.12.001_b0200","unstructured":"Kaplan S. Aquablation is proving to be an innovative and successful approach in BPH procedures. New York, NY: Mount Sinai Hospital; 2022. https:\/\/reports.mountsinai.org\/article\/uro2022-05-aquablation-is-proving-to-be-innovative-and-successful."},{"key":"10.1016\/j.euf.2023.12.001_b0205","first-page":"10378","article-title":"Aquablation for BPH","volume":"27","author":"Kasraeian","year":"2020","journal-title":"Can J Urol"},{"key":"10.1016\/j.euf.2023.12.001_b0210","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/bju.14917","article-title":"Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue trial (WATER) vs WATER II: comparing Aquablation therapy for benign prostatic hyperplasia in 30\u201380 and 80\u2013150 mL prostates","volume":"125","author":"Nguyen","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2023.12.001_b0215","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1007\/s00345-022-04137-6","article-title":"Functional and surgical outcomes of Aquablation in elderly men","volume":"40","author":"Raizenne","year":"2022","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2023.12.001_b0220","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s00345-018-2535-9","article-title":"Comparison of <100 cc prostates and >100 cc prostates undergoing Aquablation for benign prostatic hyperplasia","volume":"37","author":"Bhojani","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2023.12.001_b0225","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1007\/s12325-018-0722-0","article-title":"Pooled Aquablation results for American men with lower urinary tract symptoms due to benign prostatic hyperplasia in large prostates (60\u2013150 cc)","volume":"35","author":"Chughtai","year":"2018","journal-title":"Adv Ther"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456923002936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456923002936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T17:15:26Z","timestamp":1732641326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456923002936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2405456923002936"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2023.12.001","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Will Aquablation Be the New Benchmark for Robotic Minimally Invasive Surgical Treatment for Benign Prostatic Hyperplasia?","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2023.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}